Alasdair MacGowan
- Pharmacology top 0.1%
- Molecular Medicine top 0.05%
- Epidemiology top 1%
- Infectious Diseases top 0.5%
- Clinical Biochemistry top 0.1%
- Co-authors
- Karen E. BowkerTimothy R. WalshMandy WoottonPeter M. BennettAlan NoelH. A. HoltJohan W. MoutonRafael Cantón
- Topics
- Antibiotics Pharmacokinetics and Efficacy (138 papers)Antibiotic Resistance in Bacteria (116 papers)Bacterial Identification and Susceptibility Testing (64 papers)
- Journals
- The LancetSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- United KingdomNetherlandsSpain
In The Last Decade
Alasdair MacGowan
278 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Pharmacology 2.8k
- Molecular Medicine 2.8k
- Epidemiology 2.3k
- Infectious Diseases 2.2k
- Clinical Biochemistry 1.6k
Countries citing papers authored by Alasdair MacGowan
This map shows the geographic impact of Alasdair MacGowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alasdair MacGowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alasdair MacGowan more than expected).
Fields of papers citing papers by Alasdair MacGowan
This network shows the impact of papers produced by Alasdair MacGowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alasdair MacGowan. The network helps show where Alasdair MacGowan may publish in the future.
Co-authorship network of co-authors of Alasdair MacGowan
This figure shows the co-authorship network connecting the top 25 collaborators of Alasdair MacGowan. A scholar is included among the top collaborators of Alasdair MacGowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alasdair MacGowan. Alasdair MacGowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 33 | |
| 7 | 12 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 38 | |
| 11 | 14 | |
| 12 | 11 | |
| 13 | 15 | |
| 14 | Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study | 2 |
| 15 | 48 | |
| 16 | 17 | |
| 17 | 6 | |
| 18 | 28 | |
| 19 | The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill | 1 |
| 20 | 71 |
About Alasdair MacGowan
Alasdair MacGowan is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 284 papers that have together received 8.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (138 papers), Antibiotic Resistance in Bacteria (116 papers) and Bacterial Identification and Susceptibility Testing (64 papers). The work is most often cited by research in Molecular Medicine (2.8k citations), Applied Microbiology and Biotechnology (855 citations) and Clinical Biochemistry (1.6k citations). Alasdair MacGowan has collaborated with scholars based in United Kingdom, Netherlands and Spain. Frequent co-authors include Karen E. Bowker, Timothy R. Walsh, Mandy Wootton, Peter M. Bennett, Alan Noel, H. A. Holt, Johan W. Mouton, Rafael Cantón, Gunnar Kahlmeter and Martin Steinbakk. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.